These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 111955)

  • 1. Diminished sugar cataractogenesis by quercetin.
    Beyer-Mears A; Farnsworth PN
    Exp Eye Res; 1979 Jun; 28(6):709-16. PubMed ID: 111955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic cataracts and flavonoids.
    Varma SD; Mizuno A; Kinoshita JH
    Science; 1977 Jan; 195(4274):205-6. PubMed ID: 401544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS; Ghosh MN
    Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts.
    Varma SD; Kinoshita JH
    Biochem Pharmacol; 1976 Nov; 25(22):2505-13. PubMed ID: 825129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetic cataract and flavonoids (first results) (author's transl)].
    Leuenberger PM
    Klin Monbl Augenheilkd; 1978 Apr; 172(4):460-2. PubMed ID: 418268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of lycopene on cataract development in galactosemic rats.
    Pollack A; Madar Z; Eisner Z; Nyska A; Oren P
    Metab Pediatr Syst Ophthalmol (1985); 1996-1997; 19-20():31-6. PubMed ID: 11548783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
    Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugar alcohols in the pathogenesis of galactose and diabetic cataracts.
    van Heyningen R
    Birth Defects Orig Artic Ser; 1976; 12(3):295-303. PubMed ID: 821562
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defensive role of quercetin against imbalances of calcium, sodium, and potassium in galactosemic cataract.
    Ramana BV; Raju TN; Kumar VV; Reddy PU
    Biol Trace Elem Res; 2007 Oct; 119(1):35-41. PubMed ID: 17914217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugar metabolism in the crystalline lens.
    Chylack LT; Cheng HM
    Surv Ophthalmol; 1978; 23(1):26-37. PubMed ID: 100892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic and galactosaemic cataracts.
    James M; Crabbe C; Harding JJ
    Trans Ophthalmol Soc U K (1962); 1982; 102 Pt 3():342-5. PubMed ID: 6821010
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractive change in alloxan diabetic rabbits. Control by flavonoids I.
    Varma SD; El-Aguizy HK; Richards RD
    Acta Ophthalmol (Copenh); 1980 Oct; 58(5):748-59. PubMed ID: 6782822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effectiveness of sulindac in sugar cataracts--the implication.
    Sharma YR; Bhatnagar R; Vajpayee RB; Mohan M; Gupta SK; Mukesh K
    Dev Ophthalmol; 1989; 17():173-5. PubMed ID: 2507366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.